¹Department of Biochemistry and the Program in Research on Women's Health, Boston University School of Medicine, Boston, Massachusetts, MA 02118, USA

²Department of Environmental Health, and the Program in Research on Women's Health, Boston University Schools of Medicine and Public Health, Boston, Massachusetts, MA 02118, USA

Correspondence to: G E Sonenshein, Department of Biochemistry, Boston University Medical School, 715 Albany St., Boston, Massachusetts, MA 02118, USA

^aDH Sherr and GE Sonenshein contributed equally to this manuscript

NF-B/Rel transcription factors regulate many genes involved in control of cellular proliferation, neoplastic transformation, and apoptosis, including the c-myc oncogene. Recently, we have observed that levels of NF-B and aryl hydrocarbon receptor (AhR), which mediates malignant transformation by environmental carcinogens, are highly elevated and appear constitutively active in breast cancer cells. Rel factors have been found to functionally interact with other transcription factors. Here we demonstrate a physical and functional association between the RelA subunit of NF-B and AhR resulting in the activation of c-myc gene transcription in breast cancer cells. RelA and AhR proteins were co-immunoprecipitated from cytoplasmic and nuclear extracts of non-malignant MCF-10F breast epithelial and malignant Hs578T breast cancer cells. In transient co-transfection, RelA and AhR gene products demonstrated cooperation in transactivation of the c-myc promoter, which was dependent on the NF-B elements, and in induction of endogenous c-Myc protein levels. A novel AhR/RelA-containing NF-B element binding complex was identified by electrophoretic mobility shift analysis of nuclear extracts from RelA and AhR co-transfected Hs578T cells. Thus, the RelA and AhR proteins functionally cooperate to bind to NF-B elements and induce c-myc gene expression. These findings suggest a novel signaling mechanism whereby the Ah receptor can stimulate proliferation and tumorigenesis of mammary cells. Oncogene (2000) 19, 5498-5506.

NF-B; RelA; AhR; c-myc oncogene; breast cancer